GlassScriptPhysician profile
Amanda R Pung
NPI 1699844571
$877.86
in general payments reported to CMS, 2019-2025
16 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.00 · 2024: $650 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $258.60 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $170.96 | 2023-2024 | |
| Axsome Therapeutics, INC. | $111.92 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $69.63 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Glaxosmithkline, LLC. | $45.56 | 2024 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $28.82 | 2024 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.68 | 2024 | Synjardy, Jardiance |
| Actelion Pharmaceuticals US, INC. | $27.48 | 2024 | Opsumit, Uptravi |
| Genentech USA, INC. | $21.23 | 2024 | Xolair |
| Lundbeck LLC | $19.74 | 2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $19.24 | 2024 | |
| Daiichi Sankyo INC. | $16.95 | 2024 | Injectafer |
| Dexcom, INC. | $16.78 | 2024 | Dexcom G6 Transmitter |
| Organon LLC | $14.81 | 2024 | |
| Collegium Pharmaceutical, INC. | $14.36 | 2024 | Belbuca |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.10 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Pung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.